GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

COLL · Jun 30, 2025

COLLEGIUM PHARMACEUTICAL, INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001558370-25-010649General Corporate
Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.03% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

38.53% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

29.41% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

20.29% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

57.65% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

18.67% · CORE · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

5.75% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building
Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20250/7 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
0.45%
Current
0.03%
Delta
-0.41%
Cash Generation Increased
Previous
31.16%
Current
38.53%
Delta
7.37%
Growth Increased
Previous
22.66%
Current
29.41%
Delta
6.75%
Inventory Pressure Decreased
Previous
20.94%
Current
20.29%
Delta
-0.65%
Margin Increased
Previous
54.75%
Current
57.65%
Delta
2.90%
Profitability Increased
Previous
12.20%
Current
18.67%
Delta
6.47%
Sbc Intensity Decreased
Previous
6.48%
Current
5.75%
Delta
-0.73%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · COLL Fundamental State →Transitioned To · COLL Fundamental State →Transitioned To · COLL CAPEX_INTENSITY_DECREASED →Transitioned To · COLL CASH_GENERATION_INCREASED →Transitioned To · COLL GROWTH_INCREASED →Transitioned To · COLL INVENTORY_PRESSURE_DECREASED →Transitioned To · COLL MARGIN_INCREASED →Transitioned To · COLL PROFITABILITY_INCREASED →Transitioned To · COLL SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.